Allspring Global Investments
IBB icon

Allspring Global Investments’s iShares Biotechnology ETF IBB Stock Holding History

Allspring Global Investments’s Portfolio IBB Stock Details IBB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$8.94M Buy
52,531
+5,625
+12% +$962K 0.02% 724
2025
Q4 		$7.93M Buy
46,906
+46,806
+46,806% +$7.6M 0.01% 755
2025
Q3 		$14.4K Buy
+100
New +$13.7K ﹤0.01% 1615

Other funds holding IBB

Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return
CB
Commerce Bank Kansas City, Missouri $22.8B AUM 28.56% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Allspring Global Investments's IBB Position: Q1 2026 in Review

Allspring Global Investments increased its iShares Biotechnology ETF (IBB) stake by 12% in Q1 2026, buying an estimated $962K and bringing the position to 52,531 shares worth $8.94M. The position accounts for 0.02% of the portfolio, ranked #724.

Allspring Global Investments first reported a position in IBB in Q3 2025 and has held it in 3 quarters since. 921 funds tracked by Wall St. Rank hold IBB as of Q1 2026.

  • Allspring Global Investments held 52,531 shares of iShares Biotechnology ETF worth $8.94M as of Q1 2026.
  • Allspring Global Investments bought 5,625 iShares Biotechnology ETF shares in Q1 2026, an estimated $962K.
  • iShares Biotechnology ETF made up 0.02% of Allspring Global Investments's portfolio in Q1 2026, its #724 holding.
  • Allspring Global Investments first reported a position in iShares Biotechnology ETF in Q3 2025 and has held it in 3 quarters since.
  • 921 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q1 2026.

Based on Allspring Global Investments's 13F filing for Q1 2026, filed 5 May 2026.